Abstract

The European Union Medical Device Regulation (EUMDR 2017/745) requires medical device manufacturers to implement a risk-based approach to quality management system (ISO13485) processes. This article provides an overview of the importance of QMS processes in the medical device industry and explains the need to implement a risk-based approach to comply with EUMDR. Implementing a Risk-Based Approach to Quality Management System ISO-13485 Processes in Compliance with EUMDR 2017/745 for Medical Device Industry discusses the steps involved in implementing a risk-based approach to QMS processes, including identifying potential risks, evaluating and prioritizing risks, developing and implementing risk mitigation strategies, and monitoring and continuously improving QMS processes. Additionally, the article highlights the benefits of adopting a risk-based approach, such as improved product safety and efficacy, enhanced regulatory compliance, improved customer satisfaction, and cost savings. It also addresses the challenges in implementing a risk-based approach, including a lack of resources and expertise, resistance to change, and limited understanding of risk management principles. Overall, this article emphasizes the importance of a risk-based approach to QMS processes in the medical device industry to ensure the safety and effectiveness of medical devices and comply with regulatory requirements.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call